MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3

Published:2024-07-05 Issue:1 Volume:25 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Peng Chun¹,Li Xiaoqing¹,Yao Yuhui¹,Nie Yu¹,Fan Lingyao¹,Zhu Chuandong^ORCID

Affiliation:

1. Department of Oncology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China

Funder

Nanjing Second Hospital talent lifting plan key project

Natural Science Foundation of Nanjing University of Chinese Medicine

Medical research project general program of jiangsu Provincial Health Commission

Nanjing medical science and technology development project key project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2024.2373497

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Colorectal cancer

3. Clinical management of metastatic colorectal cancer in the era of precision medicine

4. Trends in the development of miRNA bioinformatics tools

5. miRNA Biogenesis: A Dynamic Pathway

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction;Cancer Biology & Therapy;2024-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP